Showing results (111-120 of 164) with videos related to
Sort By:
Pageof 17
European Psychiatry : the Journal of the Association of European Psychiatrists|October 5, 2014
Efficacy of lurasidone across five symptom dimensions of schizophrenia: pooled analysis of short-term, placebo-controlled studiesA Loebel, J Cucchiaro, R Silva, et al.Optics Letters|October 22, 2009
Enhanced reverse saturable absorption and optical limiting in heavy-atom-substituted phthalocyaninesJ W Perry, K Mansour, S R Marder, et al.Archives of General Psychiatry|September 1, 1979
Predicting drug-free improvement in schizophrenic psychosisS R Marder, D P van Kammen, J P Docherty, et al.The Journal of Nervous and Mental Disease|March 1, 1976
Predicting individual responses to drug treatment in schizophrenia: a test dose modelP R May, T Van Putten, C Yale, et al.Science (New York, N.Y.)|July 9, 1993
Relation between bond-length alternation and second electronic hyperpolarizability of conjugated organic moleculesS R Marder, C B Gorman, B G Tiemann, et al.Archives of General Psychiatry|March 1, 1980
Lack of behavioral supersensitivity to d-amphetamine after pimozide withdrawal. A trial with schizophrenic patientsD P van Kammen, J P Docherty, S R Marder, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 1, 1995
Distribution of fluphenazine and its metabolites in brain regions and other tissues of the ratM Aravagiri, S R Marder, A Yuwiler, et al.Psychiatry Research|December 1, 1991
T2 hyperintense foci on magnetic resonance images of schizophrenic patients and controlsG Bartzokis, H J Garber, V J Griswold, et al.Archives of General Psychiatry|March 1, 1982
Long-term pimozide pretreatment differentially affects behavioral responses to dextroamphetamine in schizophrenia. Further exploration of the dopamine hypothesis of schizophreniaD P van Kammen, J P Docherty, S R Marder, et al.Psychopharmacology|January 1, 1985
Lithium attenuates the activation-euphoria but not the psychosis induced by d-amphetamine in schizophreniaD P van Kammen, J P Docherty, S R Marder, et al.Pageof 17